Trial · NCT03541174
Adverse event totals18
The totals the trial posted for each group.
1 to 18 of 18
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Aprocitentan 12.5 mg in Part 1 (Double-blind) | 1 | 243 |
| Total, all-cause mortality | Aprocitentan 25 mg in Part 1 (Double-blind) | 0 | 245 |
| Total, all-cause mortality | Placebo in Part 1 (Double-blind) | 0 | 242 |
| Total, all-cause mortality | Aprocitentan 25 mg in Part 2 (Single-blind) | 9 | 704 |
| Total, all-cause mortality | Aprocitentan 25 mg in Part 3 (Double-blind Withdrawal) | 1 | 310 |
| Total, all-cause mortality | Placebo in Part 3 (Double-blind Withdrawal) | 0 | 303 |
| Total, other adverse events | Aprocitentan 12.5 mg in Part 1 (Double-blind) | 16 | 243 |
| Total, other adverse events | Aprocitentan 25 mg in Part 1 (Double-blind) | 34 | 245 |
| Total, other adverse events | Placebo in Part 1 (Double-blind) | 5 | 242 |
| Total, other adverse events | Aprocitentan 25 mg in Part 2 (Single-blind) | 95 | 704 |
| Total, other adverse events | Aprocitentan 25 mg in Part 3 (Double-blind Withdrawal) | 6 | 310 |
| Total, other adverse events | Placebo in Part 3 (Double-blind Withdrawal) | 4 | 303 |
| Total, serious adverse events | Aprocitentan 12.5 mg in Part 1 (Double-blind) | 8 | 243 |
| Total, serious adverse events | Aprocitentan 25 mg in Part 1 (Double-blind) | 8 | 245 |
| Total, serious adverse events | Placebo in Part 1 (Double-blind) | 3 | 242 |
| Total, serious adverse events | Aprocitentan 25 mg in Part 2 (Single-blind) | 82 | 704 |
| Total, serious adverse events | Aprocitentan 25 mg in Part 3 (Double-blind Withdrawal) | 18 | 310 |
| Total, serious adverse events | Placebo in Part 3 (Double-blind Withdrawal) | 9 | 303 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03541174/event-totals